Financial Snapshot

Revenue
$33.74M
TTM
Gross Margin
Net Earnings
$8.724M
TTM
Current Assets
Q4 2024
Current Liabilities
Q4 2024
Current Ratio
363.95%
Q4 2024
Total Assets
Q4 2024
Total Liabilities
Q4 2024
Book Value
$288.7M
Q4 2024
Cash
Q4 2024
P/E
22.24
Nov 29, 2024 EST
Free Cash Flow
$16.11M
TTM

Revenues

Revenues

Revenue YoY Change

Revenues

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997
Revenue $44.99M $37.76M $41.48M $56.16M $36.70M $30.70M $26.00M $37.50M $22.40M $23.50M $17.40M $6.400M $600.0K $0.00 $0.00 $45.30M $65.20M $60.80M $54.00M $43.10M $48.90M $61.00M $79.10M $90.60M $118.0M $13.50M $2.300M $600.0K
YoY Change 19.14% -8.98% -26.13% 53.01% 19.54% 18.08% -30.67% 67.41% -4.68% 35.06% 171.88% 966.67% -100.0% -30.52% 7.24% 12.59% 25.29% -11.86% -19.84% -22.88% -12.69% -23.22% 774.07% 486.96% 283.33%

Expenses

Cost Of Revenues

Gross Profit

Gross Profit Margin

Gross Profit

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997
Revenue $44.99M $37.76M $41.48M $56.16M $36.70M $30.70M $26.00M $37.50M $22.40M $23.50M $17.40M $6.400M $600.0K $0.00 $0.00 $45.30M $65.20M $60.80M $54.00M $43.10M $48.90M $61.00M $79.10M $90.60M $118.0M $13.50M $2.300M $600.0K
Cost Of Revenue $0.00 $16.50M $20.70M $17.20M $12.90M $11.70M $12.30M $12.80M $32.70M $54.30M $58.90M $6.700M $700.0K $300.0K
Gross Profit $0.00 $28.70M $44.50M $43.60M $41.10M $31.40M $36.60M $48.20M $46.40M $36.30M $59.00M $6.800M $1.600M $400.0K
Gross Profit Margin 63.36% 68.25% 71.71% 76.11% 72.85% 74.85% 79.02% 58.66% 40.07% 50.0% 50.37% 69.57% 66.67%

Selling, General & Admin Expense

Research & Development

Depreciation, Depletion & Amortization

SGA Expense to Gross Profit Ratio

R&D To Gross Profit Ratio

DDA To Gross Profit Ratio

Operating Expenses Total

Operating Profits/Loss

Operational Expenses

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997
Selling, General & Admin $13.14M $16.45M $13.62M $10.50M $9.600M $11.10M $4.100M $4.500M $14.20M $3.300M $1.700M $2.200M $1.500M $1.800M $17.90M $32.90M $37.20M $29.80M $29.10M $34.00M $44.10M $67.10M $106.7M $121.8M $106.7M $8.800M $1.000M
YoY Change -20.12% 20.81% 29.71% 9.38% -13.51% 170.73% -8.89% -68.31% 330.3% 94.12% -22.73% 46.67% -16.67% -89.94% -45.59% -11.56% 24.83% 2.41% -14.41% -22.9% -34.28% -37.11% -12.4% 14.15% 1112.5% 780.0%
% of Gross Profit 62.37% 73.93% 85.32% 72.51% 92.68% 92.9% 91.49% 144.61% 293.94% 206.44% 1569.12% 550.0% 250.0%
Research & Development $2.203M $3.436M $6.952M $7.347M $4.300M $1.200M $0.00 $12.80M $13.80M $12.70M $10.80M $13.20M $19.60M $21.40M $25.90M $35.60M $42.70M $12.90M $5.700M $1.000M
YoY Change -35.88% -50.58% -5.38% 70.86% 258.33% -100.0% -7.25% 8.66% 17.59% -18.18% -32.65% -8.41% -17.37% -27.25% -16.63% 231.01% 126.32% 470.0%
% of Gross Profit 44.6% 31.01% 29.13% 26.28% 42.04% 53.55% 44.4% 55.82% 98.07% 72.37% 189.71% 356.25% 250.0%
Depreciation & Amortization $1.399M $2.577M $2.599M $4.061M $12.09M $4.950M $0.00 $0.00 $10.00K $0.00 $0.00 $1.690M $1.780M $1.310M $1.580M $2.460M $6.820M $15.41M $30.55M $137.7M $882.0M $1.530M $330.0K $50.00K
YoY Change -45.71% -0.85% -36.0% -66.41% 144.24% -100.0% -100.0% -5.06% 35.88% -17.09% -35.77% -63.93% -55.74% -49.56% -77.82% -84.38% 57549.02% 363.64% 560.0%
% of Gross Profit 5.89% 4.0% 3.0% 3.84% 7.83% 18.63% 31.97% 65.84% 379.42% 1494.97% 22.5% 20.63% 12.5%
Operating Expenses $2.203M $3.436M $6.952M $25.03M $26.80M $15.80M $11.00M $4.100M $4.500M $14.20M $3.300M $1.700M $2.200M $1.500M $1.800M $31.30M $47.20M $50.10M $40.70M $42.50M $53.70M $67.10M $97.80M $270.0M $1.038B $119.5M $14.50M $1.900M
YoY Change -35.88% -50.58% -72.22% -6.61% 69.62% 43.64% 168.29% -8.89% -68.31% 330.3% 94.12% -22.73% 46.67% -16.67% -94.25% -33.69% -5.79% 23.1% -4.24% -20.86% -19.97% -31.39% -63.78% -73.98% 768.28% 724.14% 663.16%
Operating Profit $11.59M $14.65M -$1.800M -$2.600M -$2.700M -$6.500M $400.0K -$11.10M -$17.10M -$18.90M -$51.40M -$233.7M -$978.6M -$112.7M -$12.90M -$1.500M
YoY Change -20.91% -30.77% -3.7% -58.46% -1725.0% -103.6% -35.09% -9.52% -63.23% -78.01% -76.12% 768.32% 773.64% 760.0%

Interest Expenses

Interest Expenses To Operating Income %

Other Expense/Income

Interest & Other Expense/Income

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997
Interest Expense $1.849M $340.0K $1.884M -$6.000M $1.900M -$900.0K -$900.0K $600.0K -$3.700M -$800.0K -$200.0K $200.0K $300.0K $500.0K -$1.800M -$300.0K -$800.0K -$800.0K $100.0K $100.0K $100.0K $900.0K $2.100M $5.700M -$700.0K $200.0K $100.0K
YoY Change 443.82% -81.95% -131.4% -415.79% -311.11% 0.0% -250.0% -116.22% 362.5% 300.0% -200.0% -33.33% -40.0% -127.78% 500.0% -62.5% 0.0% -900.0% 0.0% 0.0% -88.89% -57.14% -63.16% -914.29% -450.0% 100.0%
% of Operating Profit 12.62% -200.0%
Other Income/Expense, Net $0.00 -$100.0K $0.00 $100.0K $0.00 $0.00 $0.00 $100.0K -$600.0K -$900.0K -$100.0K $0.00 $0.00
YoY Change -100.0% -100.0% -100.0% -116.67% -33.33% 800.0%

Income/Loss

Pretax Income

Income Tax

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

Net Profits/Loss YoY Change

Basic EPS

Net Income To Revenue Ratio

Pretax & Net Income

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997
Pretax Income $18.37M $14.61M $9.491M $33.01M $3.700M $16.80M $6.200M $24.00M $10.40M -$1.100M $13.30M $4.500M -$1.400M -$1.100M -$700.0K $34.90M -$3.700M -$7.900M -$2.200M -$17.80M -$21.50M -$20.90M -$100.4M -$939.1M -$3.072B -$119.1M -$12.60M -$1.600M
YoY Change 25.72% 53.97% -71.25% 792.19% -77.98% 170.97% -74.17% 130.77% -1045.45% -108.27% 195.56% -421.43% 27.27% 57.14% -102.01% -1043.24% -53.16% 259.09% -87.64% -17.21% 2.87% -79.18% -89.31% -69.43% 2479.35% 845.24% 687.5%
Income Tax $4.884M -$1.274M -$4.000M $7.082M -$1.500M -$7.000M $0.00 -$40.10M -$21.60M $3.300M -$10.30M -$9.800M $0.00 $0.00 $0.00 $0.00 $0.00 $200.0K $200.0K $200.0K $300.0K $300.0K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
% Of Pretax Income 26.58% -8.72% -42.15% 21.45% -40.54% -41.67% 0.0% -167.08% -207.69% -77.44% -217.78% 0.0%
Net Earnings $13.49M $15.89M $13.49M $25.93M $5.200M $23.80M $6.200M $3.000M $28.90M -$7.400M $20.77M $12.90M -$1.400M -$1.100M -$700.0K $34.90M -$3.700M -$8.000M -$2.400M -$18.00M -$21.80M -$21.20M -$96.10M -$942.9M -$3.071B -$118.7M -$12.60M -$1.600M
YoY Change -15.1% 17.76% -47.97% 398.63% -78.15% 283.87% 106.67% -89.62% -490.54% -135.64% 60.97% -1021.43% 27.27% 57.14% -102.01% -1043.24% -53.75% 233.33% -86.67% -17.43% 2.83% -77.94% -89.81% -69.3% 2487.11% 842.06% 687.5%
Net Earnings / Revenue 29.98% 42.07% 32.52% 46.17% 14.17% 77.52% 23.85% 8.0% 129.02% -31.49% 119.34% 201.56% -233.33% 77.04% -5.67% -13.16% -4.44% -41.76% -44.58% -34.75% -121.49% -1040.73% -2602.46% -879.26% -547.83% -266.67%
Basic Earnings Per Share $1.09 $1.26 $1.05 $2.03 -$0.57 $3.20
Diluted Earnings Per Share $1.08 $1.25 $1.05 $2.020M $403.1K $1.845M $473.3K $230.8K $2.223M -$0.57 $3.20 $3.146M -$341.5K -$268.3K -$170.7K $8.512M -$902.4K -$2.162M -$685.7K -$5.806M -$7.517M -$8.833M -$43.68M -$673.5M -$3.839B -$395.7M -$126.0M -$37.40M

Assets & Liabilities

Cash & Short-Term Investments

Cash & Equivalents

Cash To Operating Expenses Ratio

Inventory

No data

Receivables

Total Short-Term Assets

Property, Plant And Equipment

Long-Term Investments

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

Accounts Payable

Short-Term Debt

Long Term Debt Due

Total Short-Term Liabilities

Long-Term Debt

Other Long-Term Liabilities

Total Long-Term Liabilities

Total Liabilities

Short-Term To Long-Term Debt Ratio

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

Assets & Liabilities

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997
Cash & Short-Term Investments $4.503M $6.156M $43.90M $4.200M $13.00M $20.20M $30.60M $32.20M $47.30M $58.70M $7.700M $24.60M $38.20M $39.30M $38.60M $2.900M $3.300M $5.200M $6.200M $13.80M $16.30M $22.00M $25.50M $76.20M $18.70M $13.90M $3.300M
YoY Change -26.85% -85.98% 945.17% -67.69% -35.64% -33.99% -4.97% -31.92% -19.42% 662.34% -68.7% -35.6% -2.8% 1.81% 1231.03% -12.12% -36.54% -16.13% -55.07% -15.34% -25.91% -13.73% -66.54% 307.49% 34.53% 321.21%
Cash & Equivalents $4.503M $6.156M $42.86M $3.000M $11.20M $20.20M $30.60M $32.20M $47.30M $58.70M $7.700M $24.60M $38.20M $39.30M $6.200M $13.80M $16.30M $22.00M $25.50M $76.20M $18.70M $13.90M $3.300M
Short-Term Investments $0.00 $1.034M $1.200M $1.800M
Other Short-Term Assets $2.637M $1.114M $1.727M $500.0K $800.0K $2.800M $1.000M $1.000M $1.900M $0.00 $0.00 $0.00 $100.0K $100.0K $1.500M $2.000M $2.400M $2.000M $2.900M $3.300M $3.500M $3.200M $6.400M $13.40M $2.000M $200.0K $0.00
YoY Change 136.71% -35.5% 245.4% -37.5% -71.43% 180.0% 0.0% -47.37% -100.0% 0.0% -93.33% -25.0% -16.67% 20.0% -31.03% -12.12% -5.71% 9.38% -50.0% -52.24% 570.0% 900.0%
Inventory $0.00 $4.100M $1.000M $500.0K $0.00 $6.400M $16.70M $10.50M $14.70M $300.0K $34.50M $200.0K $200.0K
Prepaid Expenses
Receivables $4.729M $3.094M $1.803M $1.900M $2.600M $2.200M $1.600M $1.100M $1.100M $1.100M $500.0K $200.0K $0.00 $7.600M $10.20M $8.800M $6.100M $4.500M $7.900M $10.30M $15.90M $43.40M $4.700M $800.0K $0.00
Other Receivables $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Total Short-Term Assets $11.87M $10.36M $47.43M $6.700M $16.30M $25.20M $33.20M $34.20M $50.30M $59.80M $8.200M $24.80M $38.30M $39.30M $40.10M $16.60M $16.90M $16.40M $15.20M $27.90M $44.40M $46.00M $62.50M $133.3M $59.90M $15.00M $3.600M
YoY Change 14.52% -78.15% 607.87% -58.9% -35.32% -24.1% -2.92% -32.01% -15.89% 629.27% -66.94% -35.25% -2.54% -2.0% 141.57% -1.78% 3.05% 7.89% -45.52% -37.16% -3.48% -26.4% -53.11% 122.54% 299.33% 316.67%
Property, Plant & Equipment $5.438M $5.840M $5.779M $5.200M $1.300M $0.00 $0.00 $0.00 $0.00 $1.900M $2.300M $1.200M $1.800M $10.10M $15.40M $22.30M $19.40M $40.10M $8.400M $1.500M $300.0K
YoY Change -6.88% 1.06% 11.13% 300.0% -17.39% 91.67% -33.33% -82.18% -34.42% -30.94% 14.95% -51.62% 377.38% 460.0% 400.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $48.00K $76.00K $3.610M $3.700M $500.0K $500.0K $1.900M $9.600M $13.30M $13.90M $13.50M $13.00M
YoY Change -36.84% -97.89% -2.43% 640.0% 0.0% -73.68% -80.21% -27.82% -4.32% 2.96% 3.85%
Other Assets $35.91M $30.19M $25.93M $31.80M $30.00M $23.30M $22.90M $38.70M $17.60M $21.20M $10.50M $1.000M $0.00 $1.200M $1.400M $4.000M $9.900M $3.400M $2.600M $3.400M $14.00M $6.800M $2.000M $400.0K $0.00
YoY Change 18.93% 16.45% -18.47% 6.0% 28.76% 1.75% -40.83% 119.89% -16.98% 101.9% 950.0% -100.0% -14.29% -65.0% -59.6% 191.18% 30.77% -23.53% -75.71% 105.88% 240.0% 400.0%
Total Long-Term Assets $322.4M $289.3M $235.2M $267.2M $238.1M $190.5M $176.7M $174.7M $130.2M $128.4M $53.40M $20.50M $0.00 $0.00 $0.00 $17.20M $18.50M $13.90M $20.50M $22.50M $25.50M $34.60M $98.20M $846.8M $10.30M $1.900M $200.0K
YoY Change 11.45% 22.96% -11.96% 12.22% 24.99% 7.81% 1.14% 34.18% 1.4% 140.45% 160.49% -100.0% -7.03% 33.09% -32.2% -8.89% -11.76% -26.3% -64.77% -88.4% 8121.36% 442.11% 850.0%
Total Assets $334.3M $299.6M $282.7M $273.9M $254.4M $215.7M $209.9M $208.9M $180.5M $188.2M $61.60M $45.30M $38.30M $39.30M $40.10M $33.80M $35.40M $30.30M $35.70M $50.40M $69.90M $80.60M $160.7M $980.1M $70.20M $16.90M $3.800M
YoY Change
Accounts Payable $3.935M $3.902M $5.087M $3.700M $3.100M $2.600M $1.800M $700.0K $0.00 $3.600M $2.900M $2.700M $5.100M $4.300M $2.200M $3.900M $6.300M $18.00M $2.800M $700.0K $100.0K
YoY Change 0.85% -23.29% 37.49% 19.35% 19.23% 44.44% 157.14% -100.0% 24.14% 7.41% -47.06% 18.6% 95.45% -43.59% -38.1% -65.0% 542.86% 300.0% 600.0%
Accrued Expenses $800.0K $900.0K $300.0K $0.00 $200.0K $200.0K $300.0K $6.300M $8.200M $13.00M $16.30M $20.30M $20.90M $24.80M $63.90M $35.80M $8.100M $900.0K $100.0K
YoY Change -11.11% 200.0% -100.0% 0.0% -33.33% -95.24% -23.17% -36.92% -20.25% -19.7% -2.87% -15.73% -61.19% 78.49% 341.98% 800.0% 800.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $2.445M $8.000K $11.80M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $7.800M $3.100M $300.0K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change -100.0% 30462.5% -99.93% -100.0% 151.61% 933.33%
Long-Term Debt Due $7.400M $3.400M $3.400M $3.500M $1.400M $1.500M $4.200M $1.100M $0.00
YoY Change 117.65% 0.0% -2.86% 150.0% -6.67% -64.29% 281.82%
Total Short-Term Liabilities $3.944M $6.347M $5.095M $15.40M $3.100M $2.600M $1.800M $700.0K $800.0K $900.0K $400.0K $100.0K $200.0K $200.0K $300.0K $30.70M $30.40M $32.20M $43.80M $46.50M $48.30M $58.60M $93.70M $80.50M $21.30M $3.200M $300.0K
YoY Change -37.86% 24.57% -66.92% 396.77% 19.23% 44.44% 157.14% -12.5% -11.11% 125.0% 300.0% -50.0% 0.0% -33.33% -99.02% 0.99% -5.59% -26.48% -5.81% -3.73% -17.58% -37.46% 16.4% 277.93% 565.63% 966.67%
Long-Term Debt $43.13M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $5.000M $0.00 $0.00 $0.00 $0.00 $0.00 $100.0K $0.00 $0.00 $0.00 $0.00 $0.00 $100.0K $100.0K $400.0K $700.0K $100.0K
YoY Change -100.0% -100.0% -100.0% 0.0% -75.0% -42.86% 600.0%
Other Long-Term Liabilities $6.864M $13.35M $10.33M $18.00M $14.80M $0.00 $100.0K $200.0K $300.0K $400.0K $300.0K $1.000M $100.0K $100.0K $100.0K $500.0K $500.0K $1.200M $1.800M $700.0K
YoY Change -48.57% 29.14% -42.59% 21.62% -100.0% -50.0% -33.33% -25.0% 33.33% -70.0% 900.0% 0.0% 0.0% -80.0% 0.0% -58.33% -33.33% 157.14%
Total Long-Term Liabilities $50.00M $13.35M $10.33M $18.00M $14.80M $0.00 $100.0K $200.0K $300.0K $400.0K $5.300M $1.000M $100.0K $100.0K $100.0K $500.0K $600.0K $1.200M $1.800M $700.0K $0.00 $0.00 $100.0K $100.0K $400.0K $700.0K $100.0K
YoY Change 274.63% 29.14% -42.59% 21.62% -100.0% -50.0% -33.33% -25.0% -92.45% 430.0% 900.0% 0.0% 0.0% -80.0% -16.67% -50.0% -33.33% 157.14% -100.0% 0.0% -75.0% -42.86% 600.0%
Total Liabilities $53.94M $19.69M $15.43M $33.40M $17.80M $2.600M $1.900M $4.600M $5.300M $6.200M $11.30M $8.100M $300.0K $300.0K $400.0K $31.20M $31.00M $33.50M $45.50M $47.20M $48.30M $58.60M $93.80M $80.70M $21.70M $3.900M $300.0K
YoY Change 173.91% 27.63% -53.81% 87.64% 584.62% 36.84% -58.7% -13.21% -14.52% -45.13% 39.51% 2600.0% 0.0% -25.0% -98.72% 0.65% -7.46% -26.37% -3.6% -2.28% -17.58% -37.53% 16.23% 271.89% 456.41% 1200.0%

Ownership

Basic Shares Outstanding

Diluted Shares Outstanding

Preferred Stock

No data

Treasury Stock Shares

No data

Stock Issuance & Repurchase

Ownership Data

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997
Basic Shares Outstanding 12.37M shares 12.65M shares 12.84M shares 12.80M shares 12.99K shares 6.486K shares
Diluted Shares Outstanding 12.45M shares 12.70M shares 12.88M shares 12.83M shares 12.99K shares 6.492K shares
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Book Value

Free Cash Flow

Free Cash Flow YoY

Free Cash Flow Margin

Dividends

Dividends

No data

Stock Price

Market Cap: $194.02 Million

About SWK Holdings Corp

SWK Holdings Corp. engages in financial and asset management in the field of pharmaceuticals. The company is headquartered in Dallas, Texas and currently employs 22 full-time employees. The Company’s segments include Finance Receivables and Pharmaceutical Development. Finance Receivables segment is a healthcare capital provider, which offers customized financing solutions to a range of life science companies, institutions, and inventors. This segment is primarily focused on monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. Its Pharmaceutical Development segment operates through its subsidiary Enteris BioPharma, Inc. (Enteris). Enteris is a clinical development and manufacturing organization providing development services to pharmaceutical partners as well as innovative formulation solutions built around its oral drug delivery technologies, the Peptelligence platform.

Industry: Miscellaneous Business Credit Institution Peers: A-Mark Precious Metals, Inc. ACACIA RESEARCH CORP CALIFORNIA FIRST LEASING CORP FlexShopper, Inc. GWG Holdings, Inc. Sundance Strategies, Inc. LM FUNDING AMERICA, INC. Mill City Ventures III, Ltd